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Abstract
Aim:We aimed to identify the optimal method to estimate total energy expenditure (TEE) in mitochondrial disease (MD) patients.
Methods: Resting energy expenditure (REE) was measured in MD patients carrying the m3243A>G mutation using indirect
calorimetry (IC) and compared with results of 21 predictive equations (PEs) for REE and with REE-IC measurements in healthy
controls. Physical activity level (PAL) was measured using accelerometery (SenseWear) and compared with a fixed average PAL
(1.4) as well as patients’ self-estimated activity levels. TEE was calculated as REE-IC × PAL SenseWear and compared with usual
care and energy recommendations for healthy adults. Results: Thirty-eight MD patients (age: 48 ± 13 years; body mass index 24 ±
4 kg/m2; male 20%) and 25 matched controls were included. The accuracy of most PEs was between 63% and 76%. The difference
in REE-IC in healthy controls (1532 ± 182 kcal) and MD patients (1430 ± 221) was borderline not significant (P= .052). Patients’
estimations PAL were 18%–34% accurate at the individual level. The fixed activity factor was 53% accurate. Patients overestimated
their PAL. Usual care predicted TEE accurately in only 32% of patients. Conclusion: TEE is lower in these MD patients than the
recommendations for healthy adults because of their lower physical activity. In MD patients, 6 PEs for REE provide a reliable
alternative for IC, with an accuracy of 71%–76%. As PAL is highly variable and not reliably estimated by patients, measurement
of PAL using accelerometery is recommended in this population. (JPEN J Parenter Enteral Nutr. 2021;45:158–164)
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Clinical Relevancy Statement
This study provides innovative information on total energy
expenditure, which can help guide individual dietary
treatment of patients with mitochondrial disease. Energy
requirements are very relevant for this patient population
because the energy production in these patients is decreased.
Introduction
Mitochondria are responsible for the transformation of
energy from nutrients into adenosine triphosphate, through
oxidative phosphorylation (OXPHOS). Mitochondrial dys-
function can result from mutations in either nuclear
DNA or mitochondrial DNA. The incidence of primary
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mitochondrial disorders is approximately 1:5000 of all live
births.1 The most frequently reported pathogenic mito-
chondrial mutation in adults is the m.3243A>G point
mutation.1,2 The most frequently reported phenotype of the
m.3243A>G mutation is maternally inherited diabetes and
deafness (MIDD), but mitochondrial myopathy also is very
common. Mitochondrial encephalomyopathy and lactate
acidosis and stroke-like episodes (MELAS) is a more severe
phenotype with a lower incidence. Frequently occurring
symptoms are hearing loss, gastrointestinal symptoms, ex-
ercise intolerance, diabetes, andmyopathy.2 Because specific
treatment options remain limited, treatment is based on
symptoms’ management, like exercise3 and nutrition care.4
Accurate prediction of total energy expenditure (TEE)
is crucial to guide individual dietary treatment4 because
mitochondrial disease (MD) patients are at risk for both
malnutrition5-7 and overnutrition, with a higher risk for
comorbidities and metabolic syndrome.4,8,9
At this point, it is not clear if and how MD affects
energy requirements. Defects in the OXPHOS system could
theoretically lead to a lowered oxygen consumption rate at
the cellular level,10 with lower resting energy expenditure
(REE). A lower fat-free mass (FFM), as is frequently
seen in MD,4-7 might also lower the REE.11 Previously,
Fiuza-Luces et al (2016) did not find a lower oxygen
consumption rate or lower REE when assessing indirect
calorimetry (IC) in 20 children with MD.12 By contrast, the
lactic acidosis that frequently occurs in MD may induce
increases in the volume of CO2 production based on exhaled
CO2. This could mean a higher REE. The latter could
not be confirmed by Fiuza-Lucas et al (2016), although
these authors reported a nearly significant (P = .086)
increase in REE in children with MD as compared with
healthy controls.
MD patients are a heterogeneous group in whom nutri-
tion intake tends to be inadequate.13 Measuring REE using
IC is recommended,5,12 but this is a relatively expensive
method that requires the presence of trained personnel. For
this reason, REE is often estimated in an indirect manner by
means of predictive equations (PEs).14 It is know that these
PEs are not very accurate at an individual level,14 but how
accurate they are in MD is not known.
Physical activity has a major influence on TEE,15 and
it is known that patients with MD are less active than
healthy controls in this respect.8,16 Physical activity can be
reliably measured using noninvasive accelerometery.17 This,
however, is not implemented in most clinical settings, and in
usual care, physical activity level (PAL) is mostly estimated
based on anamnestic data obtained from patients or by the
use of standard PAL based on literature8 or protocols.11,18
The aim of this study was to identify the optimal method
to estimate TEE in MD patients. Also, we wanted to learn
whether the energy requirements in adultMDpatients differ
from healthy adults.
Materials and Methods
Standard Protocol Approval, Registration,
and Patient Consent
This study was conducted in accordance with good clinical
practice and the Declaration of Helsinki. The Medical
Ethics Committee of the Arnhem and Nijmegen region
approved the study protocol (NL 39724.091.13/2013/146),
and written informed consent was obtained from every
patient.
Study Design/Patients
In this study, we used baseline data of the DINAMITE
study, a randomized controlled trial with an individual
dietary intervention in adult patients with MD due to the
m.3243A>G mutation,4 as well as healthy control data
from the DYNAMO study, a cross-sectional study on the
association of body composition, physical functioning, and
protein intake in adult patients with MDs.7
Thirty-nine patients with MD due to the m.3243A>G
mutation, from the Radboudumc patient cohort, were in-
cluded in the DINAMITE study. These could participate if
theywere at least 18 years of age, had nomedical contraindi-
cation to undergo nutrition assessment after overnight fast,
had no cardiac pacemaker, and did not suffer from claus-
trophobia. Patient measurements were performed between
2014 and 2017. Maternal lactation was another exclusion
criterion for this study. Seventy-three healthy controls were
included in the DYNAMO study: we used only the data of
controls that on average matched for gender, age (±2 years),
and body mass index (BMI, ±1 kg/m2).
Data on phenotype, the Newcastle Mitochondrial Dis-
ease Adult Scale,19 and heteroplasmy levels of the mutation
measured in urinary epithelial cells20 were collected from
patient files.
Anthropometrics
Height (cm) and weight (kg) were measured. The FFM was
estimated by single-frequency bioimpedance analysis (BIA)
(Bodystat 1500 MDD) at 50 Hz; FFM (kg) was calculated
according to the formula presented by Kyle et al.21
Resting Energy Expenditure
As the gold standard for REE (kcal), IC was measured
as assessed for 20–30 minutes with the Cosmed Quark
RMR, lying down with the canopy after an overnight
fast, according to the Dutch national standard operating
procedure. The REE-IC was compared with the results of
21 PEs, including 4 that incorporate FFM (see Table S1),
and with the REE-IC of healthy controls.
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Table 1. Activity Level Scored According to Criteria From the Dutch Health Council (Gezondheidsraad)26 Translated Into
Lower and Upper PAL Values as Described by Black (1996),15 Based on Double-Labeled Water Measurements.





Chair-bound or bed-bound I use a wheelchair all the time 1.2 1.2
Seated work with no option of moving around
and little or no strenuous leisure
I have limited activity, I alternate sitting with light
housework and activities such as writing,
washing
1.4 1.5
Seated work with discretion and requirement to
move around but little or no strenuous leisure
activity
I’m moderately active, I alternate sitting with light
and heavier housework, gardening, walking,
cycling, sports
1.6 1.7
Standing work (eg, housewife, shop assistant) I’m normally active, I don’t sit very often 1.8 1.9
Strenuous work or highly active leisure I’m very active, I do heavy physical work and/or I
exercise a lot
2.0 2.4
PAL, physical activity level.
Physical Activity Level
Physical activity was measured using a validated multisen-
sor actometer22-25 (SenseWear, Bodymedia with SenseWear
Pro algorithm version 5.2), which was worn over a 7-day
period. Patients wore the device day and night; they only
were allowed to take it off for showering.
Physical activity data are presented as average metabolic
equivalents (METs) per day, in which 1 MET = resting
metabolic rate. PAL is defined as the TEE/REE. Therefore,
averageMETSwere interpreted as PAL and used as the gold
standard.
The gold standard was compared with the following:
1. Patients’ estimated activity level scored by the Dutch
activity table (see Table 1).
2. Usual care using a fixed PAL of 1.4. This was chosen
for 2 reasons:
a Apabhai et al (2011) found in 100 genetically
proved adult MD patients with SenseWear ac-
celerometery an average PAL of 1.48; this result
is consistent with the average PAL in the DINA-
MITE study.4
b Literature on PAL in patients with various
diseases advises to consider a PAL of 1.3–1.5.
This value is therefore commonly used in dietary
practice, including in our center.18
3. Average PAL in healthy Dutch adults is considered
to be 1.7 in persons up to 50 years of age and 1.6
from 50 years and older.26 The recommended PAL
is higher: 1.9–1.8.26
Total Energy Expenditure
We compared our gold standard for TEE (REE-IC × PAL
SenseWear) to usual care and energy recommendations for
healthy adults. The usual care at our center involves using
theWorldHealthOrganization (WHO) formulawithweight
and height14 as the PE for REE for patients with a BMI of
<30 kg/m2 and Harris-Benedict (1918)27 for patients with
BMI of ≥30 kg/m2, based on the study by Kruizenga et al
(2016). This estimatedREE ismultiplied with the usual-care
fixed PALof 1.4 to calculate the usual-care TEE. The energy
recommendations are based on theWHOREEPE+weight
multiplied with a PAL of 1.7 for patients <50 years old and
1.6 for patients aged 50 years and older.26
Statistics
Data were reported as means ± SD or frequencies and
percentage of the group or total population, if applicable.
Normal distribution of the variables was assessed by
Shapiro-Wilk tests. Differences between MD patients and
controls were tested using the independent t-test. Differ-
ences between estimated PAL and measured PAL and
between gold-standard TEE with energy recommendations
were tested using the paired t-test. Accuracy of predic-
tions for REE /PAL/TEE was evaluated as the percentage
of participants who predicted within ±10% of measured
REE/PAL/TEE, root-mean-square error (bias), and mean
absolute percentage difference between predicted and mea-
sured REE/PAL/TEE. Statistical analyses were performed
using SPSS statistics (IBM Statistics 23). Two-sided testing
was used in all cases, and the significance level was set at P
< .05.
Results
Thirty-eight MD patients (age: 48 ± 13 years; BMI 24
± 4 kg/m2; male 20%; patient characteristics are shown
in Table 2) and 25 matched controls (age: 46 ± 11 years;
BMI 24 ± 3 kg/m2; male 20%) were included. One patient
from the DINAMITE study was excluded because she
was lactating. Twelve controls from the DYNAMO were
excluded because they did not match for gender, age, and/or
BMI.
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Age (years) 48 ± 13
Female gender 31 (82)
BMI, kg/m2 24 (±4.2)
Underweight (BMI ≤ 18.5 kg/m2) 2 (5)
Normal (BMI 18.5–25 kg/m2) 21 (55)
Overweight (BMI 25–30 kg/m2) 12 (32)
Obesity (BMI ≥ 30 kg/m2) 3 (8)
NMDAS score 18 ± 10









Low n (%) 18 (47)
Normal n (%) 20 (53)
Self-estimated activity, n (%)
Limited activity 11 (30)
Moderately active 17 (46)
Normally active 7 (19)
Very active 2 (5)
Wheelchair use, n (%)
I don’t use a wheelchair 34 (92)




No activity-stimulating factors 16 (43)
Rehabilitation program 3 (8)
Physiotherapy 8 (22)
Sports 12 (32)
Data are shown as mean ± SD, n (%).
BMI, body mass index; FFMI, fat-free mass index; MELAS,
mitochondrial encephalomyopathy and lactate acidosis and
stroke-like episodes; METS, metabolic equivalents; MIDD,
maternally inherited diabetes and deafness; NMDAS, Newcastle
Mitochondrial Disease Adult Scale; UEC, urinary epithelial cell.
aLow or normal FFMI as compared with reference values by Pichard
et al (2004).31
Resting Energy Expenditure
Table 3 shows statistics of the 21 REE PEs for the MD
patients. The accuracy of most (n = 15) PEs was between
63% and 76%. Three out of 4 PEs that use FFM as a
variable were all <50% accurate. The 3 best-scoring REE
formulas were Henry based on weight and height,28 Muller
using FFM,29 and Harris-Benedict (1984).27 The difference
in REE-IC in healthy controls (1532 ± 182 kcal) and MD
patients (1430 ± 221) almost reached statistical significance
(P = .052); see Figure 1.
Physical Activity Level
The patients’ estimations for PAL were 18%–34% accurate
at the individual level. The fixed activity factor (1.4) was 53%
Figure 1. Resting energy expenditure measured by indirect
calorimetry (REE-IC) in mitochondrial disease (MD) patients
and healthy controls.
accurate (see Table 4). Patients overestimated their PAL.
The difference between measured and estimated PAL was
significant (P = .001 for the lower estimated PAL and P <
.001 for the higher estimated PAL).
Total Energy Expenditure
Usual care accurately predicted TEE in only 32%of patients
(see Table 5). Total energy requirements of MD patients
were significantly lower than Dutch energy recommenda-
tions (P < .0001).
Discussion
The main finding of the present study is that the method in
usual care of estimating TEE in adult MD patients seems
adequate in only 32% of all patients, whereas 6 available
PEs for REE showed an accuracy of 71%–76% and seem
a relatively reliable alternative to IC. The patients’ own
estimations for PAL proved not to be a suitable alternative
to accelerometery.
The REE-IC seemed slightly (±100 kcal) lower in MD
patients as compared with healthy controls (1430± 221 kcal
inMDpatients vs 1532± 182 in controls), but this difference
was not statistically significant (P= .052). Fiuza-Luces et al
(2016) found an opposite but nonsignificant difference (P=
.085) in REE-IC in children with MD vs controls.12 Based
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Gold standard = REE-IC 1430 221 - - - - -
Henry H + W25 1378 189 7.6e 164 76d 21 3
Muller A26 1376 184 7.8f 163 74e 24 3
H&B198423 1393 178 7.8f 159e 71f 18 11
Henry H25 1356 176 7.9 174 71f 26 3
Cole34 1345 154 7.6e 174 71f 29 0
Muller FFM26 1369 166 7.5d 160f 71f 24 5
H&B191927 1398 171 7.9 158d 68 21 11
Muller B26 1367 210 8.9 182 68 26 5
WHO W11 1422 176 8.4 162 66 16 19
Mifflin130 1324 199 8.7 192 66 34 0
Mifflin230 1320 200 8.6 195 66 34 0
Schofield H + W31 1401 175 8 167 66 21 13
Schofield W31 1418 172 8.2 162 66 16 18
WHO H + W11 1423 175 8.4 158d 63 16 21
Owen28,29 1317 172 9.1 200 63 37 0
Luis32 1474 200 10.6 197 53 13 34
Mifflin FFM30 1255 168 11.7 214 45 55 0
Weijs14 1560 204 13.5 215 37 5 58
Owen FFM28,29 1194 194 16.2 273 21 79 0
Bernstein33 1148 130 18.9 325 16 84 0
Bernstein FFM33 1068 171 25.1 383 0 100 0
Bias, root-mean-square error; FFM, fat-free mass; H, height; IC, indirect calorimetry; MD, mitochondrial disease; PE, predictive equation; REE,
resting energy expenditure; SD, standard deviation; W, weight; WHO, World Health Organization.
aAccurate estimation = REE PE between 90% and 110% of REE-IC.
bUnderestimation = REE PE <90% of REE-IC.




on these limited data, it seems fair to assume that REE of
theseMDpatients does not substantially differ from healthy
individuals and does not have clinical implications.
The accuracy of 6 PEs was between 71% and 76% (see
Table 2). This is significantly better compared with the
maximally 49% accurate predictions of Kruizenga et al14 in
a large hospital patient cohort (n = 513). This suggests that
for most MD patients, the use of 1 of these 6 PEs provides
a relatively reliable alternative to IC. Yet dietitians should
be aware that PEs remain estimations. The PEs can be used
as an aid to the initial energy estimation, which then should
be corrected according to changes in the patient’s nutrition
status.
Patients’ estimations of PAL did not prove reliable al-
ternatives for accelerometery, given their accuracy of only
18%–34%, with patients overestimating their PAL. It should
be mentioned here that the activity table that we used and
which has been validated for healthy individuals does not
seem suitable for patients with exercise intolerance. For
example, patients perform even light household tasks at
a slower pace and with lower intensity. Because of our
results, we recommend using accelerometery in all adultMD
patients as part of their nutrition assessment. This technique
is not expensive and is doable for patients, whereas the
alternatives seem inaccurate. In case this is not possible,
the use of a fixed PAL of 1.4 provides a more reliable
alternative (53%) compared with the patients’ self-estimated
PAL.
The TEE of MD patients is lower than that of recom-
mendations for healthy individuals, and because there was
no difference in REE, this difference is mainly explained
by their lower PAL. This finding is in line with previous
research in MD patients by Apabhai et al (2011).8 Because
interindividual differences in TEE may be substantial in
this very heterogeneous patient group, nutrition assessment
is recommended for accurate estimates at the individual
level.4-6
The SenseWear accelerometer has been reported
to overestimate energy expenditure in healthy adults,
especially at high intensities.25 Although patients with
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Gold standard = PAL
(SenseWear)
1.4 0.24 - - - - -
Patient-estimated lower PAL 1.6 0.17 18 0.29 34 13 53
Patient-estimated upper PAL 1.7 0.21 24 0.38 18 11 71
Usual care = fixed average PAL 1.4 - 13d 0.24d 53d 29 18
Bias, root-mean-square error; MD, mitochondrial disease; PAL, physical activity level; SD, standard deviation; SW, Sensewear.
aAccurate estimation = predictive equation PAL 90%–110% of PAL (SW).
bUnder estimation = predictive equation PAL< 90% of PAL (SW).
cOverestimation = predictive equation PAL> 110% of PAL (SW).
dBest outcome.


























Gold standard = REE (IC) × PAL
(SenseWear)
2058 414 - - - - -
Usual care = WHO11 (if BMI <30
kg/m2) or HB (1918) (if BMI ≥30
kg/m2) × 1.4
1985 243 18 422 32 37 32
Energy recommendations WHO +
W11 × 1.7 (if age <50 years) or
×1.6 (if age >50 years)
2348 281 23 498 32 11 58
Bias, root-mean square error; BMI, body mass index; H, height; HB, Harris Benedict; IC, indirect calorimetry; MD, mitochondrial disease; PAL,
physical activity level; REE, resting energy expenditure; SD, standard deviation; TEE, total energy expenditure; W, weight; WHO, World Health
Organization.
aAccurate estimation = Estimated TEE 90%–110% of gold standard TEE.
bUnderestimation = Estimated TEE <90% of gold standard TEE.
cOverestimation = Estimated TEE > 110% of gold standard TEE.
a mitochondrial disorder do not perform much intense
activities30 and the 5.2 version of the SenseWear Pro
algorithm that was used shows better validity for measuring
energy expenditure than the older 2.2 version,24 this
presents a methodological limitation. Another shortcoming
is the use of BIA to evaluate body composition. This is a
double indirect method, and BIA is known to overestimate
FFM compared with dual-energy x-ray absorptiometry
in MD patients.7 Finally, the use of the healthy energy
recommendations as a control for total energy requirements,
instead of using a healthy control group that had the
same accelerometery + IC measurements, is a limitation.
The energy recommendations for healthy adults26 are
not very recent (2006) and are based on local Dutch
recommendations stemming from the international WHO
recommendations, which are even older (2001).11
Conclusion
TEE in MD patients is lower than suggested by recom-
mendations for healthy adults because of MD patients’
lower amount of physical activity. In MD patients, 6 PEs
for REE present a relatively reliable alternative for IC
measurements. As PAL is highly variable and not reliably
estimated by patients themselves, measurement of PAL
using accelerometery is recommended in this population. If
measuring activity is not feasible, the use of a fixed PAL of
1.4 is a more reliable method than using patient-estimated
activity levels.
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